|
1
|
Ma O, Cai WW, Zender L, Davaram T, Shen J,
Herron AJ, Lowe SW, Man TK, Lau CC and Donehower LA: MMP13, Birc2
(cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate
with p53 deficiency in mouse osteosarcoma progression. Cancer Res.
69:2559–2567. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guise TA, O'keefe R, Randall RL and Terek
RM: Molecular biology and therapeutics in musculoskeletal oncology.
J Bone Joint Surg Am. 91:724–732. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fellenberg J, Bernd L, Delling G, Witte D
and Zahlten-Hinguranage A: Prognostic significance of
drug-regulated genes in high-grade osteosarcoma. Mod Pathol.
20:1085–1094. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hutchinson JN, Ensminger AW, Clemson CM,
Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts
identifies two linked noncoding RNAs associated with SC35 splicing
domains. BMC Genomics. 8:392007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin R, Maeda S, Liu C, Karin M and
Edgington TS: A large noncoding RNA is a marker for murine
hepatocellular carcinomas and a spectrum of human carcinomas.
Oncogene. 26:851–858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perez DS, Hoage TR, Pritchett JR,
Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS and
Smith DI: Long, abundantly expressed non-coding transcripts are
altered in cancer. Hum Mol Genet. 17:642–655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamada K, Kano J, Tsunoda H, Yoshikawa H,
Okubo C, Ishiyama T and Noguchi M: Phenotypic characterization of
endometrial stromal sarcoma of the uterus. Cancer Sci. 97:106–112.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tseng JJ, Hsieh YT, Hsu SL and Chou MM:
Metastasis associated lung adenocarcinoma transcript 1 is
up-regulated in placenta previa increta/percreta and strongly
associated with trophoblast-like cell invasion in vitro. Mol Hum
Reprod. 15:725–731. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gutschner T, Hämmerle M, Eißmann M, Hsu J,
Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Groß M, et al: The
noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L and Davie JR: The role of Sp1 and Sp3
in normal and cancer cell biology. Ann Anat. 192:275–283. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Safe S and Abdelrahim M: Sp transcription
factor family and its role in cancer. Eur J Cancer. 41:2438–2448.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deacon K, Onion D, Kumari R, Watson SA and
Knox AJ: Elevated SP-1 transcription factor expression and activity
drives basal and hypoxia-induced vascular endothelial growth factor
(VEGF) expression in non-small cell lung cancer. J Biol Chem.
287:39967–39981. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Wei D, Huang S, Peng Z, Le X, Wu
TT, Yao J, Ajani J and Xie K: Transcription factor Sp1 expression
is a significant predictor of survival in human gastric cancer.
Clin Cancer Res. 9:6371–6380. 2003.PubMed/NCBI
|
|
15
|
Li S, Wang Q, Qiang Q, Shan H, Shi M, Chen
B, Zhao S and Yuan L: Sp1-mediated transcriptional regulation of
MALAT1 plays a critical role in tumor. J Cancer Res Clin Oncol.
141:1909–1920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Porter W, Saville B, Hoivik D and Safe S:
Functional synergy between the transcription factor Sp1 and the
estrogen receptor. Mol Endocrinol. 11:1569–1580. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang D, Yang H, Lin J, Teng Y, Jiang Y,
Chen J and Li Y: 17β-estradiol regulates cell proliferation, colony
formation, migration, invasion and promotes apoptosis by
upregulating miR-9 and thus degrades MALAT-1 in Osteosarcoma cell
MG-63 in an Estrogen receptor-independent manner. Biochem Biophys
Res Commun. 457:500–506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nielsen MM, Tehler D, Vang S, Sudzina F,
Hedegaard J, Nordentoft I, Orntoft TF, Lund AH and Pedersen JS:
Identification of expressed and conserved human noncoding RNAs.
RNA. 20:236–251. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang F, Yi F, Han X, Du Q and Liang Z:
MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Lett.
587:3175–3181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and
Goel A: Metastasis-associated long non-coding RNA drives gastric
cancer development and promotes peritoneal metastasis.
Carcinogenesis. 35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Z, Chen C, Liu Y and Wu C:
17β-Estradiol treatment inhibits breast cell proliferation,
migration and invasion by decreasing MALAT-1 RNA level. Biochem
Biophys Res Commun. 445:388–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Parakati R and DiMario JX: Repression of
myoblast proliferation and fibroblast growth factor receptor 1
promoter activity by KLF10 protein. J Biol Chem. 288:13876–13884.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gruber CJ, Tschugguel W, Schneeberger C
and Huber JC: Production and actions of estrogens. N Engl J Med.
346:340–352. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Safe S and Kim K: Non-classical genomic
estrogen receptor (ER)/specificity protein and ER/activating
protein-1 signaling pathways. J Mol Endocrinol. 41:263–275. 2008.
View Article : Google Scholar : PubMed/NCBI
|
